Vaxart Inc (NASDAQ:VXRT) has promising data from its Norovirus program, with constructive feedback from the FDA and ...
Vaxart ( (VXRT) ) has released its Q3 earnings. Here is a breakdown of the information Vaxart presented to its investors. Vaxart, Inc. is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback